Mykhailo Buchynskyi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Systematic Review

Respiratory Syndrome Coronavirus

Gene Expression

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Ihor Vorobets, Iryna Halabitska, Aleksandr Kamyshnyi
Modulatory Roles of AHR , FFAR2 , FXR , and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes. Viruses 16 (6) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Ihor Vorobets, Iryna Halabitska, Aleksandr Kamyshnyi
Modulatory Roles of AHR , FFAR2 , FXR , and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes. Viruses 16 (6) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Ihor Vorobets, Iryna Halabitska, Aleksandr Kamyshnyi
Modulatory Roles of AHR , FFAR2 , FXR , and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes. Viruses 16 (6) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Aleksandr Kamyshnyi, Halyna Koval, Olha Kobevko, Mykhailo Buchynskyi, Valentyn Oksenych, Denis E Kainov, Katerina Lyubomirskaya, Iryna Kamyshna, Geert Potters, Olena V Moshynets
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. International journal of molecular sciences 24 (8) (2023)
Aleksandr Kamyshnyi, Halyna Koval, Olha Kobevko, Mykhailo Buchynskyi, Valentyn Oksenych, Denis E Kainov, Katerina Lyubomirskaya, Iryna Kamyshna, Geert Potters, Olena V Moshynets
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. International journal of molecular sciences 24 (8) (2023)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G Vari, Aleksandr Kamyshnyi
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis. Viruses 15 (8) (2023)
Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, Aleksandr Kamyshnyi
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. Viruses 15 (5) (2023)
Aleksandr Kamyshnyi, Halyna Koval, Olha Kobevko, Mykhailo Buchynskyi, Valentyn Oksenych, Denis E Kainov, Katerina Lyubomirskaya, Iryna Kamyshna, Geert Potters, Olena V Moshynets
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. International journal of molecular sciences 24 (8) (2023)